Forte Biosciences
NASDAQ: FBRXSherman Oaks, US · Founded 2017 · Delaware corporation
Founders & leadership
TH
Tuan HuynhNamed on SEC filing
LE
Lawrence EichenfieldNamed on SEC filing
PW
Paul WagnerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$25.2M disclosed across 2 rounds · 2018–2020
▶$19.4MraisedJun 2020 · 19 investors · BiotechnologyRule 506(b)
▶$19.4MraisedJun 2020 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Antony RileyExecutive Officer
- Paul A. Wagner, Ph.D.Executive Officer, Director
- Offering amount
- $20M
- Amount sold
- $19.4M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5.8MraisedDec 2018 · 12 investors · BiotechnologyRule 506(b)
▶$5.8MraisedDec 2018 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tuan HuynhDirector
- Lawrence EichenfieldDirector
- Paul WagnerExecutive Officer, Director
- Offering amount
- $10.7M
- Amount sold
- $5.8M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Forte Biosciences raised?
- Forte Biosciences has disclosed $25.2M raised across 2 rounds.
- Where is Forte Biosciences headquartered?
- Forte Biosciences is headquartered in Sherman Oaks, US.